Coloplast A/S (CLPBF)
74.24
-0.08
(-0.10%)
USD |
OTCM |
Nov 18, 16:00
Coloplast EPS Diluted (Quarterly) : 0.8099 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.8099 |
| June 30, 2026 | 1.009 |
| March 31, 2026 | -0.6747 |
| December 31, 2025 | 0.9661 |
| September 30, 2025 | 0.6079 |
| June 30, 2025 | 0.5425 |
| March 31, 2025 | 0.5708 |
| December 31, 2024 | 0.6627 |
| September 30, 2024 | 0.8599 |
| June 30, 2024 | 0.8179 |
| March 31, 2024 | 0.8111 |
| December 31, 2023 | 0.7999 |
| September 30, 2023 | 0.7985 |
| June 30, 2023 | 0.8736 |
| March 31, 2023 | 0.7839 |
| December 31, 2022 | 0.7272 |
| September 30, 2022 | 0.7844 |
| June 30, 2022 | 0.8669 |
| March 31, 2022 | 0.6936 |
| December 31, 2021 | 0.8698 |
| September 30, 2021 | 0.97 |
| June 30, 2021 | 0.9533 |
| March 31, 2021 | 0.8584 |
| December 31, 2020 | 0.8537 |
| September 30, 2020 | 0.7661 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.6896 |
| March 31, 2020 | 0.7372 |
| December 31, 2019 | 0.7587 |
| September 30, 2019 | 0.5542 |
| June 30, 2019 | 0.7555 |
| March 31, 2019 | 0.7272 |
| December 31, 2018 | 0.7126 |
| September 30, 2018 | 0.7629 |
| June 30, 2018 | 0.7146 |
| March 31, 2018 | 0.713 |
| December 31, 2017 | 0.6992 |
| September 30, 2017 | 0.7502 |
| June 30, 2017 | 0.6352 |
| March 31, 2017 | 0.6279 |
| December 31, 2016 | 0.6461 |
| September 30, 2016 | 0.2999 |
| June 30, 2016 | 0.6982 |
| March 31, 2016 | 0.6369 |
| December 31, 2015 | 0.5678 |
| September 30, 2015 | -1.002 |
| June 30, 2015 | 0.4922 |
| March 31, 2015 | 0.5764 |
| December 31, 2014 | 0.6278 |
| September 30, 2014 | 0.7005 |
| June 30, 2014 | 0.678 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ambu A/S | 0.1447 |
| Abbott Laboratories | 0.5294 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.0348 |
| AtriCure, Inc. | 0.0816 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 182.54M |
| Revenue (Quarterly) | 1.148B |
| Total Expenses (Quarterly) | 965.47M |
| Enterprise Value | 19.92B |
| Gross Profit Margin (Quarterly) | 65.50% |
| Profit Margin (Quarterly) | 15.90% |
| Earnings Yield | 2.84% |
| Operating Earnings Yield | 6.84% |
| Normalized Earnings Yield | 4.866 |